Vidoedo José C, Sampaio Sérgio, Cerqueira Alfredo, Vilaça Isabel, Toledo Timmy, Meira José, de Albuquerque Roncon
Serviço de Angiologia e Cirurgia Vascular do Hospital de S. João, Porto.
Rev Port Cir Cardiotorac Vasc. 2006 Jan-Mar;13(1):37-40.
We report a retrospective study of patients submitted to supragenicular femoro-popliteal bypass surgery in our department between 1998 and 2002. A SPSS package was used for statistical analysis. Eighty bypasses were performed in 74 patients with a median follow up of 19,6 months [1-71 (+/- 22,5 months)]. Leriche-Fontaine stage IV chronic ischemia was the main indication for surgery accounting for 68,8% of cases, followed by stage III (25%) and stage IIb (6,2%). The most prevalent vascular conduit was PTFE (87,5%), with great saphenous vein and Dacron being used on 7,5 % and 5% of cases. Ten patients (12,5 %) later required major amputation and limb salvage at 12, 24 and 36 months was 91,6 %, 87,7 % and 82,8 %. The primary patency rates were 81,7 %, 78,9 % and 71 % at the end of the first, second and third year of follow up. Patient survival was 92,8 %, 92,8 % e 88,6 % at 12, 24 e 36 months of follow up. A large proportion of patients (61,7 %) required an accessory procedure. Our results might be considered acceptable in face of other published results, though care must be taken given the intrinsic limitations of this retrospective study.
我们报告了一项对1998年至2002年间在我院接受膝上股腘动脉搭桥手术患者的回顾性研究。使用SPSS软件包进行统计分析。74例患者共进行了80次搭桥手术，中位随访时间为19.6个月[1 - 71（±22.5个月）]。勒里什 - 方丹IV期慢性缺血是手术的主要适应证，占病例的68.8%，其次是III期（25%）和IIb期（6.2%）。最常用的血管移植物是聚四氟乙烯（PTFE，87.5%），大隐静脉和涤纶分别用于7.5%和5%的病例。10例患者（12.5%）后来需要进行大截肢，12个月、24个月和36个月时的肢体挽救率分别为91.6%、87.7%和82.8%。随访第1年、第2年和第3年末的初次通畅率分别为81.7%、78.9%和71%。随访12个月、24个月和36个月时患者生存率分别为92.8%、92.8%和88.6%。很大一部分患者（61.7%）需要进行辅助手术。尽管考虑到这项回顾性研究的固有局限性需要谨慎，但与其他已发表的结果相比，我们的结果可能被认为是可以接受的。
